-
1دورية أكاديمية
المؤلفون: Culine, Stéphane, Harter, Valentin, Gravis, Gwenaelle, Fléchon, Aude, Chevreau, Christine, Mahammedi, Hakim, Laguerre, Brigitte, Guillot, Aline, Joly, Florence, Abadie-Lacourtoisie, Sophie, Geoffrois, Lionnel, Fiore, Frédéric Di, Roubaud, Guilhem, Barthélémy, Philippe, Voog, Eric, Emambux, Sheik, Serrate, Camille, Saldana, Carolina, Nguyen-Tan-Hon, Thierry, Loriot, Yohann, Eymard, Jean-Christophe, Huillard, Olivier, Rolland, Frédéric, Houédé, Nadine, Spano, Jean-Philippe, Demery, Mounira El, Vieillot, Sabine, L'Haridon, Tifenn, Hilgers, Werner, Allory, Yves, Pfister, Christian
المصدر: In Clinical Genitourinary Cancer December 2021 19(6):554-562
-
2دورية أكاديمية
المصدر: Anti-Cancer Drugs; Feb2012, Vol. 23 Issue 2, p143-148, 6p
-
3دورية أكاديمية
المؤلفون: Laurent M; Internal Medicine and Geriatric Department, Henri-Mondor Hospital, APHP, Créteil, France; CEpiA (Clinical Epidemiology and Aging) Unit, UPEC A-TVB DHU, IMRB,EA 7376 CEpiA University Paris Est (UPE), Créteil, France. Electronic address: marie.laurent@aphp.fr., Brureau L; Medicine Department, Gustave Roussy Cancer Center, Villejuif, France., Demery ME; Department of Oncology, Clinique du Cap d'Or, La Seyne sur Mer, France., Fléchon A; Department of Medical Oncology, Leon Bérard Cancer Center, Lyon, France., Thuaut AL; CEpiA (Clinical Epidemiology and Aging) Unit, UPEC A-TVB DHU, IMRB,EA 7376 CEpiA University Paris Est (UPE), Créteil, France; Public Health Department, Henri-Mondor Hospital, APHP, Créteil, France; Clinical Research Unit (URC Mondor), Henri-Mondor Hospital, APHP, Créteil, France., Carvahlo-Verlinde M; Department of Pharmacy, Henri-Mondor Hospital, APHP, Créteil, France., Bastuji-Garin S; CEpiA (Clinical Epidemiology and Aging) Unit, UPEC A-TVB DHU, IMRB,EA 7376 CEpiA University Paris Est (UPE), Créteil, France; Public Health Department, Henri-Mondor Hospital, APHP, Créteil, France; Clinical Research Unit (URC Mondor), Henri-Mondor Hospital, APHP, Créteil, France., Paillaud E; Internal Medicine and Geriatric Department, Henri-Mondor Hospital, APHP, Créteil, France; CEpiA (Clinical Epidemiology and Aging) Unit, UPEC A-TVB DHU, IMRB,EA 7376 CEpiA University Paris Est (UPE), Créteil, France., Canoui-Poitrine F; CEpiA (Clinical Epidemiology and Aging) Unit, UPEC A-TVB DHU, IMRB,EA 7376 CEpiA University Paris Est (UPE), Créteil, France; Public Health Department, Henri-Mondor Hospital, APHP, Créteil, France; Clinical Research Unit (URC Mondor), Henri-Mondor Hospital, APHP, Créteil, France., Culine S; Department of Medical Oncology, Saint-Louis Hospital, AP-HP, Paris, France; University Paris Diderot, Paris, France.
المصدر: Urologic oncology [Urol Oncol] 2017 Jan; Vol. 35 (1), pp. 34.e9-34.e16. Date of Electronic Publication: 2016 Oct 06.
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Withholding Treatment*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Urinary Bladder Neoplasms/*drug therapy , Urinary Bladder Neoplasms/*mortality, Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carboplatin/administration & dosage ; Cisplatin/administration & dosage ; Creatinine/blood ; Creatinine/urine ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Health Status ; Humans ; Male ; Neoplasm Metastasis ; Prospective Studies ; Serum Albumin/metabolism ; Survival Rate ; Time Factors ; Tumor Burden ; Urinary Bladder Neoplasms/pathology ; Gemcitabine